在支气管喘中改善肺功能:对舌下免疫疗法的研究
Yinming Song1, Daiyin Tian1, Sha Liu1
1National Clinical Research Center for Child Health and Disorders Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases Department of Respiratory, Children's Hospital of Chongqing Medical University Chongqing China.
Pediatric discovery
|October 2, 2025
概括
语言下特定免疫疗法改善了儿童的肺功能和喘症状. 这种治疗与标准护理相结合,减少了儿童喘患者的药物需求,并提高了儿童喘患者的整体幸福感.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 临床治疗学 临床治疗学
背景情况:
- 喘是一种慢性呼吸道疾病,影响着全世界的儿童.
- 目前的治疗方法集中在症状管理和恶化预防上.
- 特定免疫疗法在儿科喘中的作用需要进一步研究.
研究的目的:
- 评估语言下特异性免疫疗法 (SSIT) 在改善支气管喘儿童的肺功能和症状方面的疗效.
- 为了比较SSIT结合基本药物治疗和单独基本药物治疗的结果.
主要方法:
- 一项涉及256名被诊断患有支气管喘的儿童的回顾性研究.
- 参与者被分为一个实验组 (SSIT + 基本药物治疗) 和一个控制组 (仅仅是基本药物治疗).
- 肺功能 (PEF,MEF25,MMEF,MEF75,MEF50),呼吸道反应过敏以及药物剂量都在一年内进行了评估.
主要成果:
- 两组患者在一年后,肺功能显著改善,呼吸道反应过敏减少 (P<0.05).
- 与对照组相比,接受SSIT的实验组表现出更好的改善 (P < 0.05).
- SSIT导致了喘药物所需剂量的减少.
结论:
- 语言下特异性免疫疗法,当与吸入性皮质类固醇疗法相结合时,为儿科喘提供了积极的治疗效果.
- SSIT可以有效地减少药物需求,并缓解喘儿童的症状.
- 这种免疫疗法方法对改善儿童群体的长期喘管理具有前景.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K